Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. (Record no. 14436599)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01433 a2200421 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250514165011.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200402s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0030-2414 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1159/000074641 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Raderer, Markus |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20040227 |
245 00 - TITLE STATEMENT | |
Title | Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Oncology |
Date of publication, distribution, etc. | 2003 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 306-10 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Murine-Derived |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antigens, CD20 |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Epitopes, B-Lymphocyte |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunotherapy |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphoma, B-Cell, Marginal Zone |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retrospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rituximab |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jäger, Gerald |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brugger, Stefan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Püspök, Andreas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fiebiger, Wolfgang |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Drach, Johannes |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wotherspoon, Andrew |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chott, Andreas |
773 0# - HOST ITEM ENTRY | |
Title | Oncology |
Related parts | vol. 65 |
-- | no. 4 |
-- | p. 306-10 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1159/000074641">https://doi.org/10.1159/000074641</a> |
Public note | Available from publisher's website |
No items available.